{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T15:52:47Z","timestamp":1784735567540,"version":"3.55.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.intimp.2026.116583","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T17:00:27Z","timestamp":1775494827000},"page":"116583","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["H3K4 methylation of CALB2 facilitates immune evasion and chemoradiotherapy resistance in cholangiocarcinoma through KRT7-mediated PD-L1 upregulation"],"prefix":"10.1016","volume":"179","author":[{"given":"Songping","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiankang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huichun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2026.116583_bb0005","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.3390\/cancers13102358","article-title":"Novel pharmacological options in the treatment of cholangiocarcinoma: mechanisms of resistance","volume":"13","author":"Marin","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.intimp.2026.116583_bb0010","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/liv.14100","article-title":"Medical treatment for cholangiocarcinoma","volume":"39","author":"Adeva","year":"2019","journal-title":"Liver Int."},{"key":"10.1016\/j.intimp.2026.116583_bb0015","article-title":"Overcome drug resistance in cholangiocarcinoma: new insight into mechanisms and refining the preclinical experiment models","volume":"12","author":"Zheng","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.intimp.2026.116583_bb0020","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3390\/ijms18010149","article-title":"Autocrine and paracrine mechanisms promoting chemoresistance in cholangiocarcinoma","volume":"18","author":"Cadamuro","year":"2017","journal-title":"IJMS"},{"key":"10.1016\/j.intimp.2026.116583_bb0025","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.3390\/biom10111474","article-title":"Targeting P53 as a future strategy to overcome gemcitabine resistance in biliary tract cancers","volume":"10","author":"Wu","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.intimp.2026.116583_bb0030","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.path.2022.05.006","article-title":"The molecular pathogenesis and targeted therapies for cholangiocarcinoma","volume":"15","author":"Param","year":"2022","journal-title":"Surg. Pathol. Clin."},{"key":"10.1016\/j.intimp.2026.116583_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2024.11.008","article-title":"Inhibiting intracellular CD28 in cancer cells enhances antitumor immunity and overcomes anti-PD-1 resistance via targeting PD-L1","volume":"43","author":"Yang","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.intimp.2026.116583_bb0040","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1158\/1940-6207.CAPR-22-0052","article-title":"Anti-inflammatory drugs decrease the PD-L1 expression and increase the CD8+ T-cell infiltration","volume":"15","author":"Rao","year":"2022","journal-title":"Cancer Prev. Res."},{"key":"10.1016\/j.intimp.2026.116583_bb0045","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1016\/j.ymthe.2024.06.006","article-title":"Patel, targeting PD-L1 in cholangiocarcinoma using nanovesicle-based immunotherapy","volume":"32","author":"Gondaliya","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.intimp.2026.116583_bb0050","doi-asserted-by":"crossref","DOI":"10.1186\/s12957-020-02082-5","article-title":"PD-1\/PD-L1 expression profiles within intrahepatic cholangiocarcinoma predict clinical outcome","volume":"18","author":"Tian","year":"2020","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.intimp.2026.116583_bb0055","doi-asserted-by":"crossref","first-page":"12","DOI":"10.5483\/BMBRep.2021.54.1.241","article-title":"Current understanding of cancer-intrinsic PD-L1: regulation of expression and its protumoral activity","volume":"54","author":"Yadollahi","year":"2021","journal-title":"BMB Rep."},{"key":"10.1016\/j.intimp.2026.116583_bb0060","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3390\/biom10101377","article-title":"Omics-based platforms: current status and potential use for cholangiocarcinoma","volume":"10","author":"Chang","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.intimp.2026.116583_bb0065","article-title":"Epigenetic regulation of the expression of T cell stimulatory and inhibitory factors by histone H3 lysine modification enzymes and its prognostic roles in glioblastoma","volume":"38","author":"Lee","year":"2023","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.intimp.2026.116583_bb0070","doi-asserted-by":"crossref","first-page":"5595","DOI":"10.2147\/JIR.S377678","article-title":"The DPY30-H3K4me3 Axis-mediated PD-L1 expression in melanoma","volume":"15","author":"Zhang","year":"2022","journal-title":"JIR"},{"key":"10.1016\/j.intimp.2026.116583_bb0075","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1369\/00221554221119543","article-title":"Expression of calbindin-D28K in the developing and adult mouse cochlea","volume":"70","author":"Liu","year":"2022","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.intimp.2026.116583_bb0080","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1038\/cdd.2014.67","article-title":"Crucial role of calbindin-D28k in the pathogenesis of Alzheimer\u2019s disease mouse model","volume":"21","author":"Kook","year":"2014","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.intimp.2026.116583_bb0085","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.039195","article-title":"Calbindin 2 as a novel biomarker and therapeutic target for abdominal aortic aneurysm: integrative analysis of human proteomes and genetics","volume":"14","author":"Bao","year":"2025","journal-title":"JAHA"},{"key":"10.1016\/j.intimp.2026.116583_bb0090","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-024-03201-w","article-title":"CALB2 drives pancreatic cancer metastasis through inflammatory reprogramming of the tumor microenvironment","volume":"43","author":"Tao","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.intimp.2026.116583_bb0095","doi-asserted-by":"crossref","first-page":"6102","DOI":"10.1021\/acs.analchem.1c03562","article-title":"All-ion monitoring-directed low-abundance protein quantification reveals CALB2 as a key promoter in hepatocellular carcinoma metastasis","volume":"94","author":"Chu","year":"2022","journal-title":"Anal. Chem."},{"key":"10.1016\/j.intimp.2026.116583_bb0100","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/hepr.13867","article-title":"Automated image analysis of keratin 7 staining can predict disease outcome in primary sclerosing cholangitis","volume":"53","author":"Sj\u00f6blom","year":"2022","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.intimp.2026.116583_bb0105","doi-asserted-by":"crossref","first-page":"534","DOI":"10.3892\/ol.2012.756","article-title":"Expression of keratin 20 and its clinicopathological significance in intrahepatic cholangiocarcinoma","volume":"4","author":"Choi","year":"2012","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.intimp.2026.116583_bb0110","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-021-02670-6","article-title":"DZNep promotes mouse bone defect healing via enhancing both osteogenesis and osteoclastogenesis","volume":"12","author":"Cao","year":"2021","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.intimp.2026.116583_bb0115","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.bbadis.2018.03.026","article-title":"Animal models of cholangiocarcinoma","volume":"1865","author":"Loeuillard","year":"2019","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.intimp.2026.116583_bb0120","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.add7464","article-title":"PTEN deficiency facilitates gemcitabine efficacy in cancer by modulating the phosphorylation of PP2Ac and DCK","volume":"15","author":"Jiang","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.intimp.2026.116583_bb0125","first-page":"4325","article-title":"Molecular chemotherapy combined with radiation therapy enhances killing of cholangiocarcinoma cells in vitro and in vivo","volume":"57","author":"Pederson","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2026.116583_bb0130","doi-asserted-by":"crossref","DOI":"10.1080\/15384047.2023.2216041","article-title":"CSTF2T facilitates pancreatic adenocarcinoma growth and metastasis by elevating H3K4Me1 methylation of CALB2 via ASH2L","volume":"24","author":"Liu","year":"2023","journal-title":"Cancer Biol. Therapy"},{"key":"10.1016\/j.intimp.2026.116583_bb0135","doi-asserted-by":"crossref","DOI":"10.1002\/bies.202200239","article-title":"Broad H3K4me3 domains: maintaining cellular identity and their implication in super-enhancer hijacking","volume":"45","author":"Kent","year":"2023","journal-title":"BioEssays"},{"key":"10.1016\/j.intimp.2026.116583_bb0140","doi-asserted-by":"crossref","first-page":"634","DOI":"10.3390\/brainsci11050634","article-title":"New approach for untangling the role of uncommon calcium-binding proteins in the central nervous system","volume":"11","author":"Kelemen","year":"2021","journal-title":"Brain Sci."},{"key":"10.1016\/j.intimp.2026.116583_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020276","article-title":"Johnston, calbindin 2 (CALB2) regulates 5-fluorouracil sensitivity in colorectal Cancer by modulating the intrinsic apoptotic pathway","volume":"6","author":"Stevenson","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2026.116583_bb0150","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1243871","article-title":"Mahabady, emerging insights into keratin 7 roles in tumor progression and metastasis of cancers","volume":"13","author":"Hosseinalizadeh","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.intimp.2026.116583_bb0155","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1080\/19490976.2019.1695494","article-title":"Fusobacterium nucleatum promotes colorectal cancer metastasis by modulating KRT7-AS\/KRT7","volume":"11","author":"Chen","year":"2020","journal-title":"Gut Microbes"},{"key":"10.1016\/j.intimp.2026.116583_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2025.111887","article-title":"Wen, CALB2 facilitates macrophage M2 polarization to promote the growth and metastasis of pancreatic adenocarcinoma","volume":"134","author":"Hu","year":"2025","journal-title":"Cell. Signal."},{"key":"10.1016\/j.intimp.2026.116583_bb0165","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3892\/or.2020.7886","article-title":"Yang, KRT7 promotes epithelial-mesenchymal transition in ovarian cancer via the TGF-\u03b2\/Smad2\/3 signaling pathway","volume":"45","author":"An","year":"2020","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.intimp.2026.116583_bb0170","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1016\/j.ymthe.2024.09.026","article-title":"Cha, PD-L1: from cancer immunotherapy to therapeutic implications in multiple disorders","volume":"32","author":"Lee","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.intimp.2026.116583_bb0175","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3892\/or.2020.7831","article-title":"Chu, PD-L1\/PD-1 blockade in breast cancer: the immunotherapy era (review)","volume":"45","author":"Li","year":"2020","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.intimp.2026.116583_bb0180","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1007\/s00262-023-03520-5","article-title":"PD-1 and PD-L1 inhibitors in cold colorectal cancer: challenges and strategies","volume":"72","author":"Lin","year":"2023","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.intimp.2026.116583_bb0185","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.molcel.2019.09.030","article-title":"Mechanisms controlling PD-L1 expression in cancer","volume":"76","author":"Cha","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.intimp.2026.116583_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2024.01.008","article-title":"Ciccia, SMARCAL1 is a dual regulator of innate immune signaling and PD-L1 expression that promotes tumor immune evasion","volume":"187","author":"Leuzzi","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2026.116583_bb0195","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-019-1073-4","article-title":"Wang, EGFR-TKI resistance promotes immune escape in lung cancer via increased PD-L1 expression","volume":"18","author":"Peng","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.intimp.2026.116583_bb0200","doi-asserted-by":"crossref","DOI":"10.1002\/adbi.202000017","article-title":"Immune escape mediated by exosomal PD-L1 in cancer","volume":"4","author":"Lawler","year":"2020","journal-title":"Adv. Biosyst."},{"key":"10.1016\/j.intimp.2026.116583_bb0205","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djw283","article-title":"The MLL1-H3K4me3 axis-mediated PD-L1 expression and pancreatic cancer immune evasion","volume":"109","author":"Lu","year":"2017","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.intimp.2026.116583_bb0210","doi-asserted-by":"crossref","first-page":"8323","DOI":"10.3390\/ijms21218323","article-title":"Various aspects of calcium signaling in the regulation of apoptosis, autophagy, cell proliferation, and cancer","volume":"21","author":"Patergnani","year":"2020","journal-title":"IJMS"},{"key":"10.1016\/j.intimp.2026.116583_bb0215","doi-asserted-by":"crossref","first-page":"6187","DOI":"10.1111\/febs.16133","article-title":"Zhao, calcium signaling in cancer progression and therapy","volume":"288","author":"Wu","year":"2021","journal-title":"FEBS J."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926004285?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926004285?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T15:09:09Z","timestamp":1777129749000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926004285"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":43,"alternative-id":["S1567576926004285"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116583","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"H3K4 methylation of CALB2 facilitates immune evasion and chemoradiotherapy resistance in cholangiocarcinoma through KRT7-mediated PD-L1 upregulation","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116583","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116583"}}